Another Psychedelics Company Joins 'Exclusive Nasdaq Group' With Enveric's Acquisition Of MagicMed Industries
CBD-focused biotechnology company Enveric Biosciences (NASDAQ: ENVB) confirmed Monday it will acquire psychedelics company MagicMed Industries in an all-stock deal.
